SFT2D2 anticorps (N-Term)
Aperçu rapide pour SFT2D2 anticorps (N-Term) (ABIN954770)
Antigène
Voir toutes SFT2D2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-30, N-Term
-
Specificité
- Recognizes SFT2D2 (N-term).
-
Purification
- Protein A column followed by peptide Affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of Human SFT2D2 Genename: SFT2D2
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SFT2D2 (SFT2 Domain Containing 2 (SFT2D2))
-
Sujet
- PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2-linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed than the other phospholipids examined.Synonyms: SFT2 domain-containing protein 2, Vesicle transport protein SFT2B
-
ID gène
- 375035
-
NCBI Accession
- NP_955376
Antigène
-